Clinical Trial Update: PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML [Phase 2]

View source ↗

Summary

Phase 2 PEARL trial evaluating asciminib for early treatment of chronic myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• SCEMBLIX (ASCIMINIB)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: CML, Chronic Phase, Chronic Myeloid Leukemia, Chronic Phase | Phase 2 | Status: RECRUITING